NDC 63304-175 – Mesalamine
Mesalamine 1.2 g/1 · Tablet, Delayed Release · Oral
Product NDC63304-175
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Tablet, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA211858
- Marketed since
- February 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 1.2 g/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 63304-175-13 | 120 TABLET, DELAYED RELEASE in 1 BOTTLE (63304-175-13) | Feb 1, 2019 |
Recalls mentioning this NDC
- D-0268-2024 Jan 31, 2024 · Class II
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Other Mesalamine products
- 0591-2245 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Actavis Pharma, Inc.
- 60687-397 Mesalamine 1.2 g/1 · Tablet, Delayed Release · American Health Packaging
- 60687-408 Mesalamine 800 mg/1 · Tablet, Delayed Release · American Health Packaging
- 65162-360 Mesalamine 800 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals LLC
- 42291-489 Mesalamine 800 mg/1 · Tablet, Delayed Release · AvKARE
- 72162-2213 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Bryant Ranch Prepack
- 72162-2231 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Bryant Ranch Prepack
- 31722-043 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Camber Pharmaceuticals, Inc.
- 62135-714 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Chartwell RX, LLC
- 51407-900 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Golden State Medical Supply, Inc.
- 0527-3012 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Lannett Company Inc.
- 0904-6832 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Major Pharmaceuticals